Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac OutcomesSteven E. Lipshultz, Stephen E. Sallan, Caroline Laverdière et al.|PEDIATRICS|2012Cited by 176
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemiaSteven E. Lipshultz, Lewis B. Silverman, Stuart R. Lipsitz et al.|Cancer|2013Cited by 160
High Incidence of Vertebral Fractures in Children With Acute Lymphoblastic Leukemia 12 Months After the Initiation of TherapyNathalie Alos, Leanne M. Ward, Ronald Grant et al.|Journal of Clinical Oncology|2012Cited by 126
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL ConsortiumLynda M. Vrooman, Stephen E. Sallan, Donna Neuberg et al.|European Journal of Cancer|2011Cited by 117
Impact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of LeukemiaJinhui Ma, Leanne M. Ward, Kerry Siminoski et al.|The Journal of Clinical Endocrinology & Metabolism|2018Cited by 20